Arsenal Medical secures $14M U.S. Army contract for ResQFoam trauma product

Arsenal Medical was granted a contract of more than $14 million from the U.S. Army to complete clinical and manufacturing development and regulatory submission for its ResQFoam trauma product.

“Arsenal Medical today announced that it has been granted a contract of more than $14 million to complete clinical and manufacturing development and the U.S. regulatory submission process to support product approval for its lead product candidate, ResQFoamTM.”arsenalmedical.com

• 1 source
• arsenalmedical.comArsenal Medical Secures Funding from U.S. Army to Advance ResQFoamTM Trauma Product through Regulatory Approval - Arsenal MedicalJun 30, 2022

Summarized from public sources; check the original articles before acting on it.